Search

everythinglearnresearchcommunity

for

Search:↓

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Platelet-rich plasma therapy helps improve atrophic acne scars.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Platelet-rich treatments can help improve wound healing and tissue repair.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Exosomes help nerve fibers grow by affecting specific cell signaling pathways.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Sebaceous glands in our skin, developing during pregnancy and active in puberty, produce sebum for skin lubrication, temperature control, and fighting germs, also help in hormone regulation, and their dysfunction can cause conditions like acne and hair loss.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Finasteride improves heart function and repairs damage after heart attack in mice.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.